80063769 - 23rd Annual Current Topics in Gastrointestinal and Liver Pathology- EM

Thursday, December 28, 2023, 12:00 PM - Monday, December 28, 2026, 12:00 PM


This 23rd annual conference is intended as a practical overview for pathologists who encounter gastrointestinal and liver specimens in daily practice. Interpretation of biopsies of the upper GI tract mucosa and the liver will be addressed, as well as recent advances in pancreatic and biliary pathology. Case presentations will be featured to emphasize presented concepts. Participants should come away with a better understanding of interpretation of mucosal biopsies, liver biopsies, pancreatic/biliary disorders and the application of modern techniques to gastrointestinal disorders.

1. Discuss the differential diagnosis between dysplasia and reactive non-neoplastic atypia.
2. Discuss practical and clinically relevant issues in the diagnosis and staging of colorectal carcinoma.
3. Discuss new targetable options in biliary and colon cancer.
4. Recall the current performance and uncertainties of “liquid biopsy” multi-cancer early detection tests.
5. Explain the clinical significance of response to neoadjuvant treatment.
6. Recognize recently described patterns of inflammation associated with STI of the digestive tract.
7. Discuss the role and advances in circulating tumor DNA.
8. Discuss the use of special stains and immunohistochemical stains in the work up of liver tumors.
9. Differentiate between indolent and aggressive lymphoproliferative disorders of the GI tract.
10. Recognize challenges in small biopsies, frozen sections, and grossing of biliary neoplasms.
11. Discuss various neuroendocrine tumors across the length of the GI tract.
12. Discuss several types of GI mesenchymal tumors, with emphasis on their location and depth in the GI tract.
13. List the criteria used to classify the three main mass-forming precancerous neoplasms of the pancreas (Intraductal papillary mucinous neoplasms, intraductal oncocytic papillary neoplasms, and Intraductal tubulopapillary neoplasms).

Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Presenter and Provider Disclosure
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education. 

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with ineligible companies from any individual in a position to control the content of a CME activity sponsored by OCME.

The following relationships have been reported for this activity:

     NAME                                     ROLE                                        RELATIONSHIPS

Robert Anders, MD               Presenter                     Advisor: AstraZeneca, Bristol-Myers Squibb, Merck and Company
                                                                                        Grant or Research Support: Bristol-Myers and RAPT Therapeutics

Valerie Lee, MD                      Presenter                    Grant or Research Support: Merck and Company, Inc.

Jason Park, MD, PhD            Presenter                     Ownership: OncoSeer Diagnostics and Targeted Diagnostics and Therapeutics

Lysandra Voltaggio, MD     Activity Director         Grant or Research Support: Pentax Medical

No one else in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with ineligible companies.  All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

OTHER CREDITS
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Association of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

This activity has been registered to offer credit in the American Board of Pathology (ABPath) Maintenance of Certification program for up to 12.25 credits.

SYLLABUS AND LOG IN INFORMATION
The syllabus and zoom webinar link will be accessible online and via your mobile device in the CloudCME App one week prior to the activity start date. To access, please visit our website. CME Website: https://hopkinscme.cloud-cme.com(Sign In, Click My CME tab, Click Syllabus)

An outcome survey will be sent to all physician attendees within two months post activity to assist us in determining what impact this activity had on the learner’s practice.

JOHNS HOPKINS STATEMENT OF RESPONSIBILITY
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

COPYRIGHT
All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

INTERNET CME POLICY
The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its internet site as an information resource and service for physicians, other health professionals and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This activity is produced for educational purposes only. Use of Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

HARDWARE/SOFTWARE REQUIREMENTS
Internet connection.

AMERICANS WITH DISABILITIES ACT
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

 

Agenda and Speaker Listing

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.